ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest glp-1 news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks glp-1 across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Ascletis announced ASC37, a once-monthly subcutaneous GLP-1R/GIPR/GCGR triple peptide agonist. In a diet-induced obese mouse model, ASC37 demonstrated superior weight loss compared to other treatments.
Summaries by ByteBrief